Media playback is unsupported on your device

GlaxoSmithKline to pay $3bn in US drug fraud scandal

3 July 2012 Last updated at 03:18 BST

GlaxoSmithKline (GSK) is to pay $3bn (£1.9bn) in the largest healthcare fraud settlement in US history.

The drug giant is to plead guilty to promoting two drugs for unapproved uses and failing to report safety data about a diabetes drug to the Food and Drug Administration (FDA).

The settlement will cover criminal fines as well as civil settlements with the federal and state governments.

Michelle Fleury reports.